Study of AK139 in healthy volunteers
This trial tests a new medicine called AK139 in healthy people to see how safe it is and how the body processes it. It is for healthy adults aged 18 to 55.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old
- Be in good general health
- Weigh at least 110 lbs (50 kg) for men or 99 lbs (45 kg) for women, and have a body mass index between 19 and 26
- If you are a woman able to have children, you must have a negative pregnancy test
- Not have certain infections like hepatitis B, hepatitis C, HIV, or syphilis
- Not have taken any other experimental drug in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new drug called AK104 works in the body by measuring how it moves through the bloodstream. Researchers are looking for healthy men to help understand if this drug is safe and how it behaves, which could eventually help cancer patients.
This trial tests how a new drug called RNK08954 is processed by the body after food, and how it is eliminated. It is for healthy adults who want to help researchers understand the drug's safety and effects.
This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.
This trial tests a new drug called AK0610 in healthy volunteers aged 18 to 50. It helps researchers understand how the drug works in the body and whether it is safe before moving to larger studies.
This study tests the safety and how the body processes a new drug called AK0406 in healthy adults. If you are generally healthy and match the age and weight requirements, you may be able to help researchers understand if the drug is safe before it is tested in people with a medical condition.
This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.